MILAGROS ROJAS: Open Payments
NPI 1447837406 · WOODLAND PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 49 payments from 9 companies in 2025. Trend: 2023 $1,648 · 2024 $1,400 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $208 |
| Axsome Therapeutics, Inc. | 7 | $176 |
| ABBVIE INC. | 11 | $168 |
| GlaxoSmithKline, LLC. | 12 | $144 |
| Medtronic, Inc. | 1 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Exact Sciences Corporation | 2 | $56 |
| PFIZER INC. | 2 | $42 |
| Amgen Inc. | 2 | $34 |
Products named: Symbravo, Ozempic, CLOSUREFAST, QULIPTA, AIRSUPRA, NUCALA, VRAYLAR, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
